@article{{MRA}{}, author = {Blank, M., Mandel, M., Dror, N., Solomon, A., Barlyia, T., Lavie, D.}, title = { Hypericin targets multiple signaling mediators in cancer cells generating unique, diverse anti-tumoral, anti-metastatic, and anti-angiogenic activities with evidence for clinical applicability}, journal = {Medical Research Archives}, volume = {5}, number = {3}, year = {2017}, url = {https://esmed.org/MRA/mra/article/view/881} }